A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer
Journal
-
- Annals of Oncology
-
Annals of Oncology 31 (5), 619-625, 2020-05
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360857597714893952
-
- ISSN
- 09237534
-
- Data Source
-
- Crossref